Rho kinase inhibition with fasudil in the SOD1G93A mouse model of amyotrophic lateral sclerosis-symptomatic treatment potential after disease onset

René Günther*, Alexander Balck, Jan C. Koch, Tobias Nientiedt, Michael Sereda, Mathias Bähr, Paul Lingor, Lars Tönges

*Korrespondierende/r Autor/-in für diese Arbeit
13 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Rho kinase inhibition with fasudil in the SOD1G93A mouse model of amyotrophic lateral sclerosis-symptomatic treatment potential after disease onset“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie